摘要
目的观察唑来磷酸联合化疗对肺癌骨转移的止痛效果和不良反应。方法将60例确诊肺癌患者随机分为A、B2组,A组为唑来磷酸联合化疗组,B组单用唑来磷酸组。结果A、B2组止痛有效率分别为86.67%、80.00%。结论唑来磷酸联合化疗治疗肺癌骨转移性疼痛安全有效。
[ Objective] To investigate the antalgic effect and adverse reactions of zoledronic acid combined with chemotherapy in treatment of bone metastasis of lung cancer. [ Methods ] 60 confirmed lung cancer patients were randomly divided into two groups ( group A and group B ). Group A was treated with zoledronic acid combined with chemotherapy, and group B was treated with zoledronic acid alone. [Results]The antalgic effective rate of group A and group B was 86.67% and 80.00%, respectively. [ Conclusion] Zoledronic acid combined with chemotherapy in treatment of bone metastasis of lung cancer is effective and safe.
出处
《职业与健康》
CAS
2009年第21期2350-2351,共2页
Occupation and Health
关键词
肺癌骨转移
联合化疗
唑来磷酸
Bone metastasis of lung cancer
combined with chemotherapy
Zoledronie acid